Free Annual Reports
St Jude Medical and Other Big Movers In Healthcare
The Nasdaq is trading up 0.8%, the S&P 500 has moved up 0.3% and the Dow has increased 0.3%, marking a bad morning for the market. The healthcare sector is the category of stocks relating to medical and healthcare goods or services. This sector includes hospital management firms, health maintenance organizations (HMOs), biotechnology and a variety of medical products. Stocks in the healthcare sector are often considered to be defensive because the products and services are essential. Even during economic downturns, people will still require medical aid and medicine to overcome illness. Having a consistent demand for goods and services makes this sector less sensitive to business cycle fluctuations.
The Healthcare sector (XLV) is down 0.3% on a good day for the market overall. The biggest movers in the sector so far are:
Beginner's Guide To Thinkorswim Trading Platform
After a precipitous drop of 27.9%, Idenix Pharmaceuticals (Nasdaq:IDIX) is now trading at a share price of $5.99. The company's volume is currently 14.4 million shares. Yesterday, volume was only 1.3 million shares. Volume is also used as a secondary indicator to help confirm what the price movement is suggesting. When estimating the value of a particular investment, valuation ratios provide a good basis for assessing the value of an individual stock. The debt ratio shows the proportion of assets that a company is financing through debt. IDIX's debt ratio is 52.3%. However, one thing to note with this ratio: it isn't a pure measure of a company's debt (or indebtedness), as it also includes operational liabilities, such as accounts payable and taxes payable.
Falling 7.4%, Perrigo (Nasdaq:PRGO) is currently at a share price of $107.97. At 1.8 million shares, the company's volume so far today is 4.2 times the average daily volume. If a stock price makes a big move up or down, volume lets us know the significance of that move. Investment valuation ratios can be very useful in determining the value of a stock, but it is very important to keep in mind that while some financial ratios have general rules (or a broad application), in most instances it is a prudent practice to look at a company's historical performance and use peer company/industry comparisons to put any given company's ratio in perspective. The price/earnings to growth (PEG) ratio compares a company's P/E ratio to its earnings-per-share growth rate, which tells you whether or not you are getting a good value when purchasing a stock with a high price/earnings ratio (P/E ratio). PEG ratio for PRGO is 2.05. While P/E ratios are important indicators of market value, a high P/E in and of itself is not bad because it may indicate a company whose earnings are growing very rapidly, so many investors look at the PEG ratio in order to get an idea of whether or not a particular P/E ratio is justified by underlying earnings growth.
After an increase of 5.7%, Genomic Health (Nasdaq:GHDX) has reached a current price of $36.25. So far today, 112,324 shares have changed hands. Volume is used to evaluate how meaningful the price movement of a stock is. Understanding investment valuation ratios allows an investor to assess the true value of an individual stock. One of the favorite tools of many value investors is analyzing price/book value ratios, as it provides a measure of the underlying value of a company's assets as compared to the valuation of its equity. The P/B ratio for GHDX is 8.22, indicating that the stock is trading for more than its book value. This may be a sign that the company is overvalued. One problem with the P/B value ratio is that it can be difficult to calculate the true book value of a company, so investors should be aware that many measures of book value may provide only a rough estimate, and should be taken with a grain of salt. SEE: Investment Valuation Ratios: Price/Book Value Ratio
Myriad Genetics (Nasdaq:MYGN) is trading at $23.74 per share, down 5%. So far today, the company's volume is 1.2 million shares, 1.7 times its average over the past three months. Price change alone is not enough to know how a stock is doing. Volume is an important secondary indicator used to confirm trends suggested by price movement. Investors can make use of valuation ratios to estimate whether a stock is fairly valued. The price/sales ratio measures a company's stock market price by its revenues. MYGN's P/S ratio of 4.07 is on the high side. This could be a good sign if the share price increases. It is important to keep in mind when looking at the P/S ratio that just because a company is generating revenues, this does not mean that the company is profitable, and in the long run, profits drive stock prices.
MAKO (Nasdaq:MAKO) has risen 4.9% and is currently trading at $16.15 per share. The company is trading at a volume of 592,441 shares. This is on pace to reach yesterday's trading volume of one million shares. Volume is an important indicator because it indicates how significant a price shift is. Investment valuation ratios provide investors with an estimation, albeit a simplistic one, of the value of a stock. The easy-to-calculate debt ratio is helpful to investors looking for a quick take on the leverage for a company. MAKO has a debt ratio of 22.7%, which is fairly low. This indicates that the company engages in conservative financing with opportunities to borrow in the future at no significant risk. As with all financial ratios, a company's debt ratio should be compared with the industry average or similar companies.
Slipping 4.2%, Onyx Pharmaceuticals (Nasdaq:ONXX) is currently trading at $67.71 per share. So far today, the company's volume is 839,623 shares, 0.6 times the average daily volume. If a stock price moves on high volume, this means that the change is a significant one. Investment valuation ratios can be very useful in estimating whether a stock price is too high, reasonable or a bargain investment opportunity. The price/earnings to growth (PEG) ratio is calculated by dividing the price/earnings ratio by growth in earnings-per-share; the lower the PEG ratio, the more reasonably valued the security. ONXX's PEG ratio is -28.12. Because of the adjustment for earnings growth rate, the PEG ratio is somewhat more useful than many formulas for comparing companies in different industries.
St Jude Medical (NYSE:STJ) is down 2.6% to reach $37.56 per share. The company is currently trading a volume of two million shares. When a stock price moves up or down, watching the volume is a good way of identifying how significant that shift is. It is important for an investor to estimate the value of any potential or existing investment; valuation ratios make this easier. The price/book value ratio, often expressed simply as "price-to-book", provides investors a way to compare the market value, or what they are paying for each share, to a conservative measure of the value of the firm. STJ's stock is trading for more than its book value with a P/B ratio of 2.6. It is important to take the company's debt into account when using the P/B ratio as debt can boost a company's liabilities to the point where they wipe out much of the book value of its hard assets, creating artificially high P/B values. All else being equal, a stock with a low P/B value ratio is more attractive than a stock with a high ratio. SEE: How Buybacks Warps The Price-To-Book Ratio
The Bottom Line The nature of the market is such that stocks will have good days and bad days. Daily stock performance should be weighed against historical performance and put in context of the market overall. Keep in mind that all these ratios should be compared against historical numbers and industry information in order to get a more complete picture.
The Healthcare sector (XLV) is down 0.3% on a good day for the market overall. The biggest movers in the sector so far are:
| Company | Market Cap | Percentage Change |
| Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) | $1.09 billion | -27.9% |
| Perrigo Company (Nasdaq:PRGO) | $10.89 billion | -7.4% |
| Genomic Health, Inc. (Nasdaq:GHDX) | $1.04 billion | +5.7% |
| Myriad Genetics, Inc. (Nasdaq:MYGN) | $2.12 billion | -5% |
| MAKO Surgical Corp. (Nasdaq:MAKO) | $656.8 million | +4.9% |
| Onyx Pharmaceuticals, Inc. (Nasdaq:ONXX) | $4.6 billion | -4.2% |
| St Jude Medical (NYSE:STJ) | $12.11 billion | -2.6% |
After a precipitous drop of 27.9%, Idenix Pharmaceuticals (Nasdaq:IDIX) is now trading at a share price of $5.99. The company's volume is currently 14.4 million shares. Yesterday, volume was only 1.3 million shares. Volume is also used as a secondary indicator to help confirm what the price movement is suggesting. When estimating the value of a particular investment, valuation ratios provide a good basis for assessing the value of an individual stock. The debt ratio shows the proportion of assets that a company is financing through debt. IDIX's debt ratio is 52.3%. However, one thing to note with this ratio: it isn't a pure measure of a company's debt (or indebtedness), as it also includes operational liabilities, such as accounts payable and taxes payable.
Falling 7.4%, Perrigo (Nasdaq:PRGO) is currently at a share price of $107.97. At 1.8 million shares, the company's volume so far today is 4.2 times the average daily volume. If a stock price makes a big move up or down, volume lets us know the significance of that move. Investment valuation ratios can be very useful in determining the value of a stock, but it is very important to keep in mind that while some financial ratios have general rules (or a broad application), in most instances it is a prudent practice to look at a company's historical performance and use peer company/industry comparisons to put any given company's ratio in perspective. The price/earnings to growth (PEG) ratio compares a company's P/E ratio to its earnings-per-share growth rate, which tells you whether or not you are getting a good value when purchasing a stock with a high price/earnings ratio (P/E ratio). PEG ratio for PRGO is 2.05. While P/E ratios are important indicators of market value, a high P/E in and of itself is not bad because it may indicate a company whose earnings are growing very rapidly, so many investors look at the PEG ratio in order to get an idea of whether or not a particular P/E ratio is justified by underlying earnings growth.
After an increase of 5.7%, Genomic Health (Nasdaq:GHDX) has reached a current price of $36.25. So far today, 112,324 shares have changed hands. Volume is used to evaluate how meaningful the price movement of a stock is. Understanding investment valuation ratios allows an investor to assess the true value of an individual stock. One of the favorite tools of many value investors is analyzing price/book value ratios, as it provides a measure of the underlying value of a company's assets as compared to the valuation of its equity. The P/B ratio for GHDX is 8.22, indicating that the stock is trading for more than its book value. This may be a sign that the company is overvalued. One problem with the P/B value ratio is that it can be difficult to calculate the true book value of a company, so investors should be aware that many measures of book value may provide only a rough estimate, and should be taken with a grain of salt. SEE: Investment Valuation Ratios: Price/Book Value Ratio
MAKO (Nasdaq:MAKO) has risen 4.9% and is currently trading at $16.15 per share. The company is trading at a volume of 592,441 shares. This is on pace to reach yesterday's trading volume of one million shares. Volume is an important indicator because it indicates how significant a price shift is. Investment valuation ratios provide investors with an estimation, albeit a simplistic one, of the value of a stock. The easy-to-calculate debt ratio is helpful to investors looking for a quick take on the leverage for a company. MAKO has a debt ratio of 22.7%, which is fairly low. This indicates that the company engages in conservative financing with opportunities to borrow in the future at no significant risk. As with all financial ratios, a company's debt ratio should be compared with the industry average or similar companies.
Slipping 4.2%, Onyx Pharmaceuticals (Nasdaq:ONXX) is currently trading at $67.71 per share. So far today, the company's volume is 839,623 shares, 0.6 times the average daily volume. If a stock price moves on high volume, this means that the change is a significant one. Investment valuation ratios can be very useful in estimating whether a stock price is too high, reasonable or a bargain investment opportunity. The price/earnings to growth (PEG) ratio is calculated by dividing the price/earnings ratio by growth in earnings-per-share; the lower the PEG ratio, the more reasonably valued the security. ONXX's PEG ratio is -28.12. Because of the adjustment for earnings growth rate, the PEG ratio is somewhat more useful than many formulas for comparing companies in different industries.
St Jude Medical (NYSE:STJ) is down 2.6% to reach $37.56 per share. The company is currently trading a volume of two million shares. When a stock price moves up or down, watching the volume is a good way of identifying how significant that shift is. It is important for an investor to estimate the value of any potential or existing investment; valuation ratios make this easier. The price/book value ratio, often expressed simply as "price-to-book", provides investors a way to compare the market value, or what they are paying for each share, to a conservative measure of the value of the firm. STJ's stock is trading for more than its book value with a P/B ratio of 2.6. It is important to take the company's debt into account when using the P/B ratio as debt can boost a company's liabilities to the point where they wipe out much of the book value of its hard assets, creating artificially high P/B values. All else being equal, a stock with a low P/B value ratio is more attractive than a stock with a high ratio. SEE: How Buybacks Warps The Price-To-Book Ratio
The Bottom Line The nature of the market is such that stocks will have good days and bad days. Daily stock performance should be weighed against historical performance and put in context of the market overall. Keep in mind that all these ratios should be compared against historical numbers and industry information in order to get a more complete picture.
by
Investopedia Staff
Investopedia.com believes that individuals can excel at managing their financial affairs. As such, we strive to provide free educational content and tools to empower individual investors, including thousands of original and objective articles and tutorials on a wide variety of financial topics.
Free Annual Reports
